Dr Adele Hosseini

Chief Scientific Officer, Bod Australia


Dr. Adele Hosseini has over 18 years’ experience leading the delivery of successful clinical trials including first in human pharmaceuticals and medical devices. Dr. Hosseini has also been involved in many aspects of healthcare including academia such as university lecturing, product development within pharmaceutical, biotech, medical device. She is a pioneer in the Australian medicinal cannabis industry-leading Bod Australia’s Scientific Advisory Board and research program. Over the last three years Dr. Hosseini has developed a deep understanding of medicinal cannabis and continues the strategic direction and development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications.

Plant to patient: unlocking the potential opportunities
Back to program
Back to Speakers

Bod Australia

Bod Australia is an ASX-listed company committed to providing the highest quality non-intoxicating cannabinoid medicines to improve patient care.
Read more
Join Us!

Register your interest to attend and stay up to date with our latest news.